Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the spe... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2010 |
Schlagwörter: | Sciences bio-médicales et agricoles / Aged / 80 and over / Bone Density Conservation Agents -- therapeutic use / Diphosphonates -- therapeutic use / Estrogen Receptor Modulators -- therapeutic use / Estrogen Replacement Therapy / Evidence-Based Medicine -- methods / Female / Humans / Organometallic Compounds -- therapeutic use / Osteoporosis / Postmenopausal -- drug therapy / Osteoporotic Fractures -- prevention & control / Thiophenes -- therapeutic use / Bisphosphonate / Raloxifene / Strontium / Teriparatide |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26916379 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/143057 |
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect. ; Consensus Development Conference ; Journal Article ; Practice Guideline ; SCOPUS: cp.j ; info:eu-repo/semantics/published